Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients

NCT02704806 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-03-10

No results posted yet for this study

Summary

Researchers use FCM to analyze the immunol cell feature and its corresponding activation status, as well as the thromb aspirated through the thromb aspiration device in AMI patients

Conditions

  • Immunol Feature in Circulation and Thromb in AMI Patients

Sponsors & Collaborators

  • Jilin University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2018-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704806 on ClinicalTrials.gov